Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399)

China flag China · Delayed Price · Currency is CNY
10.94
+0.05 (0.46%)
Dec 27, 2024, 3:04 PM CST
-6.73%
Market Cap 14.15B
Revenue (ttm) 5.45B
Net Income (ttm) -146.31M
Shares Out 1.47B
EPS (ttm) -0.10
PE Ratio n/a
Forward PE 20.66
Dividend n/a
Ex-Dividend Date n/a
Volume 2,891,760
Open 11.25
Previous Close 10.89
Day's Range 10.83 - 11.25
52-Week Range 6.89 - 12.54
Beta 0.48
Analysts n/a
Price Target n/a
Earnings Date Mar 29, 2025

About Shenzhen Hepalink Pharmaceutical Group

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium A... [Read more]

Sector Healthcare
Founded 1998
Employees 2,080
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.